Medifast, Inc. (MED)
| Market Cap | 109.85M -33.5% |
| Revenue (ttm) | 385.79M -36.0% |
| Net Income | -18.67M |
| EPS | -1.70 |
| Shares Out | 10.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 150,712 |
| Open | 10.41 |
| Previous Close | 10.48 |
| Day's Range | 10.28 - 10.68 |
| 52-Week Range | 10.10 - 15.46 |
| Beta | 0.54 |
| Analysts | Hold |
| Price Target | 12.00 (+12.68%) |
| Earnings Date | Feb 17, 2026 |
About MED
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND,... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to one analyst, the rating for MED stock is "Hold" and the 12-month stock price target is $12.0.
News
Scientific Evidence Demonstrates OPTAVIA®'s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
BALTIMORE--(BUSINESS WIRE)--As part of its continued focus on improving metabolic health, Medifast® (NYSE: MED) today announced that OPTAVIA's comprehensive metabolic health system is available for re...
Medifast, Inc. (MED) Q4 2025 Earnings Call Transcript
Medifast, Inc. (MED) Q4 2025 Earnings Call Transcript
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the fourth quarter and full ye...
Medifast Is A Net-Net With Negative Enterprise Value
Medifast trades below net cash, with an EV of -$43.68M, reflecting deep skepticism about its OPTAVIA MLM business and turnaround prospects. GLP-1 drugs have rendered MED's weight-loss model largely ob...
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter and full ...
People Magazine Spotlights Tiffany Howard's Metabolic Health Journey with OPTAVIA®
BALTIMORE--(BUSINESS WIRE)--Medifast® (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, celebrates the inspiring health transformation o...
OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity
BALTIMORE--(BUSINESS WIRE)--Medifast® (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, premiered its newest docuseries episode, “Health...
Medifast Announces Planned Leadership Transition
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced a planned leadership transition designed to provide continuity and stability as the company continues its evolution toward metabo...
OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing
BALTIMORE--(BUSINESS WIRE)--OPTAVIA, the science-backed, coach-guided lifestyle system, announced a new report “Metabolic Health in America: Awareness, Attitudes and Action.” The report includes findi...
Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference
BALTIMORE--(BUSINESS WIRE)--Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the charge in addressing the growing health crisis ...
Medifast, Inc. (MED) Q3 2025 Earnings Call Transcript
Medifast, Inc. ( MED) Q3 2025 Earnings Call November 3, 2025 4:30 PM EST Company Participants Steven Zenker - Vice President of Investor Relations Daniel Chard - Executive Chairman & CEO James Malone...
Medifast Announces Third Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended Septem...
Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today announced a strategic transformation, unveiling a n...
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quar...
Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes
BALTIMORE--(BUSINESS WIRE)--With more than 90% of U.S. adults classified as metabolically unhealthy1, the silent crisis of metabolic dysfunction continues to escalate. This condition can be linked to ...
Medifast, Inc. (MED) Q2 2025 Earnings Call Transcript
Medifast, Inc. (NYSE:MED) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET Company Participants Daniel R. Chard - Executive Chairman & CEO James P.
Medifast Announces Second Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter...
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quart...
Medifast: Coach Surge Fuels Growth
Initiate Medifast with Strong Buy and $56 PT, citing overlooked operational inflection and coach network momentum driving above-consensus FY26 revenue growth. ASCEND product line and digital engagemen...
Medifast, Inc. (MED) Q1 2025 Earnings Call Transcript
Medifast, Inc. (NYSE:MED) Q1 2025 Earnings Conference Call April 28, 2025 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and CEO Jim Maloney -...
Medifast Announces First Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ...
Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect
Medifast, Inc.'s business is deteriorating as GLP-1 medication has lowered demand, causing a vicious flywheel effect as coaches are exiting the platform. The company is trying to reposition itself as ...
Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript
Medifast, Inc. (NYSE:MED) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and Chief Executiv...
Medifast Announces Fourth Quarter and Full Year 2024 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter...
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourt...